ライフサイエンスコーパス: corticotropin-releasing factor receptor

1 NMR structure of the analogous domain of the corticotropin-releasing factor receptor.

2 The CRF system consists of two receptors, corticotropin releasing factor receptor 1 (CRF1R) and co

3 technique to a member of a class B GPCR, the corticotropin releasing factor receptor 1 (CRF1R).

4 Administration of the selective corticotropin-releasing factor receptor 1 (CRF(1)) antag

5 In addition, we examined the role of the corticotropin-releasing factor receptor 1 (CRF(1)) in th

6 We aimed to characterize the effects of the corticotropin-releasing factor receptor 1 (CRF-R1) antag

7 noradrenergic (NE) receptors (alpha1) via a corticotropin-releasing factor receptor 1 (CRF-R1)-depen

8 rial evaluating the efficacy of GSK561679, a corticotropin-releasing factor receptor 1 (CRF1 receptor

9 We describe a novel corticotropin-releasing factor receptor 1 (CRF1) antagon

10 Blockade of corticotropin-releasing factor receptor 1 (CRF1) suppres

11 Corticotropin-releasing factor receptor 1 (CRFR1) mediat

12 Similarly to what has been observed for the corticotropin-releasing factor receptor 1 (CRFR1), SAP97

13 me proliferator-activated receptor gamma and corticotropin-releasing factor receptor 1 were notable e

14 ecifically activated by either neurokinin I, corticotropin-releasing factor receptor 1, or dopamine D

15 tuted pyridyl)pyrazolo[1,5-a]-1,3,5-triazine corticotropin releasing factor receptor-1 (CRF(1)) recep

16 methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazine corticotropin releasing factor receptor-1 (CRF(1)) recep

17 ing affinity of 4-anilinopyrimidines against corticotropin-releasing factor receptor-1 (CRF(1)) (e.g.

18 Corticotropin-releasing factor receptor-1 (CRF(1)) media

19 n in the BNST is unaffected by alpha1-AR and corticotropin-releasing factor receptor-1 (CRFR(1)) anta

20 Effects on attention were attenuated by the corticotropin-releasing factor receptor-1 antagonist ant

21 opin releasing factor receptor 1 (CRF1R) and corticotropin releasing factor receptor 2 (CRF2R), a non

22 analysis showed significant upregulation of corticotropin releasing factor receptor 2 (CrfR2) in the

23 Mice deficient in corticotropin-releasing factor receptor 2 (CRF2) (C57BL/

24 Corticotropin-releasing factor receptor 2 (CRFR2) is fou

25 duction of melanogenesis; this suggests that corticotropin releasing factor receptor alternative spli

26 cyclic imidazo[4,5-b]pyridin-2-ones as human corticotropin-releasing factor receptor (CRF(1)) antagon

27 ss, the physiological consequence of central corticotropin-releasing factor receptor (CRF-R) activati

28 The corticotropin-releasing factor receptor (CRF-R) contains

29 n and structural characterization of the rat corticotropin releasing factor receptor (CRFR) gene was

30 viously reported differential involvement of corticotropin-releasing factor receptor (CRFR) 1 and 2 i

31 In our continued studies on corticotropin releasing factor receptor (CRFR1) signalin

32 c disruption of signaling through the type 1 corticotropin-releasing factor receptor (CRFR1).

33 Corticotropin-Releasing Factor Receptors (CRFRs) are cla

34 Corticotropin-releasing factor receptors (CRFRs), class

35 mutants with constitutive activation of the corticotropin-releasing factor receptor family homologue

36 A nonbinding corticotropin-releasing factor receptor mutant is shown

37 The current study examines the role of corticotropin releasing factor receptor subtypes 1 and 2

38 nvestigated here the interaction between the corticotropin releasing factor receptor type 1 (CRF1R) a

39 The coding region of the hamster corticotropin releasing factor receptor type 1 was seque

40 d, we took the CRF(2(a))R and the homologous corticotropin-releasing factor receptor type 1 (CRF(1)R)

41 esent study investigated whether blockade of corticotropin-releasing factor receptor type 1 (CRF-R1)

42 n reflect reductions in anandamide driven by corticotropin-releasing factor receptor type 1 (CRF1) po

43 we investigated interactions of the class B corticotropin-releasing factor receptor type 1 (CRF1R) w

44 Corticotropin-releasing factor receptor type 1 (CRFR1) i

45 Contact sites between the corticotropin-releasing factor receptor type 1 (CRFR1),

46 ular membrane compartments, we show that the corticotropin-releasing factor receptor type 1 has a spe

47 ure of the transmembrane domain of the human corticotropin-releasing factor receptor type 1 in comple

48 The corticotropin-releasing factor receptor type 1 is a clas

49 Corticotropin-releasing factor receptor type 1, CRF1, pl

50 here this equilibrium is established for the corticotropin-releasing factor receptor type 1.

51 The physiological consequences of activating corticotropin-releasing factor receptor type 2 (CRF2) ar

52 vation of the central stress response, while corticotropin-releasing factor receptor type 2 (CRFR2) h

53 Corticotropin-releasing factor receptor type 2 (CRFR2) h

54 eviously, we observed abnormal expression of corticotropin-releasing factor receptor type 2 (CRFR2) t

55 The corticotropin-releasing factor receptor type 2a (CRF(2(a